Cargando…
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases
Although carbohydrate antigen 19-9 (CA 19-9) may be elevated in benign diseases, elevated CA 19-9 may cause a fear of cancer and unnecessary follow-up studies. Research on how to approach systematically in this case is very limited. The purpose of this study was to analyze the clinical features and...
Autores principales: | Kim, Sunyoung, Park, Byung Kyu, Seo, Jeong Hun, Choi, Jinyoung, Choi, Jong Won, Lee, Chun Kyon, Chung, Jae Bock, Park, Yongjung, Kim, Dong Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264353/ https://www.ncbi.nlm.nih.gov/pubmed/32483216 http://dx.doi.org/10.1038/s41598-020-65720-8 |
Ejemplares similares
-
Radiotherapy Prolongs Biliary Metal Stent Patency in Malignant Pancreatobiliary Obstructions
por: Park, Semi, et al.
Publicado: (2013) -
Efficacy and Safety of Pancreatobiliary Endoscopic Procedures during Pregnancy
por: Lee, Jae Joon, et al.
Publicado: (2015) -
Role of radiotherapy for pancreatobiliary neuroendocrine tumors
por: Lee, Jeongshim, et al.
Publicado: (2013) -
Advances in systemic therapy for advanced pancreatobiliary malignancies
por: Halfdanarson, Thorvardur R, et al.
Publicado: (2013) -
The Expanding Role of Contrast-Enhanced Endoscopic Ultrasound in Pancreatobiliary Disease
por: Choi, Jun-Ho, et al.
Publicado: (2015)